Literature DB >> 3559554

An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate.

R E Paulsen, A Contestabile, L Villani, F Fonnum.   

Abstract

The effect of intrastriatal injection of fluorocitrate on amino acid pattern, cell enzyme markers, and ultrastructural appearance was investigated. A dose of 1 nmol of fluorocitrate resulted in temporarily decreased levels of glutamine, glutamate, and aspartate, whereas the level of alanine was increased. The glutamine level was severely reduced after 4 h but was reversed after 24 h. The activity of different cellular enzyme markers did not change markedly after this dose. Ultrastructural changes in glial cells were observed, concomitant with the biochemical changes. A dose of greater than or equal to 2 nmol of fluorocitrate resulted in more marked and irreversible changes in amino acid levels. By 24-72 h after the injection of this dose, several marker enzyme activities decreased markedly. The ultrastructural changes affected the neurons as well as the glial cells and were not reversible. The use of microinjection of 1 nmol of fluorocitrate into the neostriatum of the rat to provide a model for studying transmitter amino acid metabolism in brain devoid of glial cell activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559554     DOI: 10.1111/j.1471-4159.1987.tb05674.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  70 in total

1.  Glutamate-glutamine cycle and aging in striatum of the awake rat: effects of a glutamate transporter blocker.

Authors:  G Segovia; A Del Arco; L Prieto; F Mora
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain.

Authors:  S Kanematsu; S Ishii; A Umino; T Fujihira; A Kashiwa; N Yamamoto; A Kurumaji; T Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

3.  Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus.

Authors:  Karin Borges; Dayna McDermott; Hasan Irier; Yoland Smith; Raymond Dingledine
Journal:  Exp Neurol       Date:  2006-06-21       Impact factor: 5.330

Review 4.  Fluoroacetate and fluorocitrate: mechanism of action.

Authors:  D D Clarke
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

5.  Purinergic control of vascular tone in the retina.

Authors:  Joanna Kur; Eric A Newman
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

6.  Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.

Authors:  Shi Di; Ion R Popescu; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

7.  Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection.

Authors:  Bapurao Surnar; Uttara Basu; Bhabatosh Banik; Anis Ahmad; Brian Marples; Nagesh Kolishetti; Shanta Dhar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

8.  Infusion of gliotoxins or a gap junction blocker in the prelimbic cortex increases alcohol preference in Wistar rats.

Authors:  J Miguel-Hidalgo; Y Shoyama; V Wanzo
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

9.  Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.

Authors:  Erin D Milligan; Carin Twining; Marucia Chacur; Joseph Biedenkapp; Kevin O'Connor; Stephen Poole; Kevin Tracey; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Neuroprotective effects of ethyl pyruvate on brain energy metabolism after ischemia-reperfusion injury: a 31P-nuclear magnetic resonance study.

Authors:  Osamu Tokumaru; Chihiro Kuroki; Noriko Yoshimura; Tetsuro Sakamoto; Hidehiro Takei; Kazue Ogata; Takaaki Kitano; Naoko Nisimaru; Isao Yokoi
Journal:  Neurochem Res       Date:  2008-11-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.